The global biopharmaceutical cold chain third-party logistics (3PL) market is entering a sustained growth phase as pharmaceutical manufacturers increasingly rely on specialized logistics partners to manage the rising complexity of temperature-sensitive drug distribution. According to the newly released “Biopharmaceutical Cold Chain Third Party Logistics Market Forecast to 2033” report, the market was valued at $30.59 […]
Biopharmaceutical Cold Chain 3PL Market Poised to Reach $74.46B by 2033 Amid Surge in Temperature-Sensitive Drug Demand


